The main goals of our current study are to systematically dissect the PCa cell heterogeneity via assessing a spectrum of PCa cell line and xenograft models as well as primary tumor cells and samples, to address the relationship between and among different PCSC subpopulations, and dissect the relationship between PCSCs and AR, PSA, and castration resistance. The gene discussed is KLK3; the disease is neoplasm.